Drugs / genetically modified dendritic cells + cytokine-induced killer
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT02688686 | Feb 2016 → Feb 2018 | non-small cell lung carcinoma | Affiliated Hospital to Academy of Military Medical Sciences | Unknown | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | genetically modified dendritic cells + cytokine-induced killer | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02688686 ↗ |
| Known as | CIK | “cytokine-induced killer (CIK) cells” NCT02688686 ↗ |
| Modality | Cell therapy | “cytokine-induced killer (CIK) cells” NCT02688686 ↗ |